SS Innovations International, Inc. announced on April 24, 2025, that its common stock has been approved for listing on The Nasdaq Capital Market. Trading under the ticker symbol 'SSII' is expected to commence on April 25, 2025.
This uplisting is a significant milestone intended to enhance market awareness of SS Innovations' growth story, improve transparency, and expand its audience of potential investors. The company anticipates this will ultimately increase share liquidity.
The timing of the Nasdaq uplisting coincides with SS Innovations' global expansion beyond India into countries such as Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, and Ukraine. The company is also pursuing EU CE Mark and U.S. FDA approval for its SSi Mantra surgical robotic system, anticipated in late 2025 and early 2026, respectively.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.